Quoin Pharmaceuticals, Ltd. Skyrocketed
Tue, Nov 11, 2025 at 07:09 PM
Quoin Pharmaceuticals, Ltd. (QNRX:NASDAQ) rocketted at $11.51, representing a gain of 39.5%. On Tue, Nov 11, 2025, QNRX:NASDAQ hit a New 2-Week Intraday High of $14.03. The stock appeared on our News Catalysts scanner on Sat, Nov 08, 2025 at 08:50 PM in the 'INVESTOR UPDATE' category. From Tue, Oct 28, 2025, the stock recorded 20.00% Up Days and 9.09% Green Days
The stock spiked on Fri, Oct 10, 2025 at $41.8 with a volume of 13M+.
About Quoin Pharmaceuticals, Ltd. (QNRX:NASDAQ)
Quoin Pharmaceuticals Ltd is a pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases.
Top 10 Gainers:
- LEIFRAS Co. Ltd. (LFS:NASDAQ), 576.79%
- Ridgetech, Inc. (RDGT:NASDAQ), 73.81%
- Hempacco Co., Inc. (HPCO:NASDAQ), 50%
- Surmodics, Inc. (SRDX:NASDAQ), 49.72%
- enGene Holdings Inc. (ENGN:NASDAQ), 46.76%
- PubMatic, Inc. (PUBM:NASDAQ), 43.4%
- Quoin Pharmaceuticals, Ltd. (QNRX:NASDAQ), 39.52%
- The RealReal, Inc. (REAL:NASDAQ), 38.09%
- Galecto, Inc. (GLTO:NASDAQ), 36.7%
- Lead Real Estate Co., Ltd (LRE:NASDAQ), 36.46%